Matches in Wikidata for { <http://www.wikidata.org/entity/Q90596252> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q90596252 description "article scientifique publié en 2018" @default.
- Q90596252 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q90596252 description "scientific article published on 14 June 2018" @default.
- Q90596252 description "wetenschappelijk artikel" @default.
- Q90596252 description "наукова стаття, опублікована в червні 2018" @default.
- Q90596252 name "Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise" @default.
- Q90596252 name "Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise" @default.
- Q90596252 type Item @default.
- Q90596252 label "Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise" @default.
- Q90596252 label "Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise" @default.
- Q90596252 prefLabel "Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise" @default.
- Q90596252 prefLabel "Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise" @default.
- Q90596252 P1433 Q90596252-4790C71C-0DF1-4953-81F7-309BA301353F @default.
- Q90596252 P1476 Q90596252-1A3AFD69-3866-4714-BC4C-24987863DD5C @default.
- Q90596252 P2093 Q90596252-17A1FC1B-7746-45F8-973E-66E70273DCC4 @default.
- Q90596252 P2093 Q90596252-1D354465-E5FB-400D-BFA4-9AFF142F5C65 @default.
- Q90596252 P2093 Q90596252-AE526C46-19B2-4BF8-BDFD-C4F16698D7A6 @default.
- Q90596252 P2093 Q90596252-E52246ED-C52C-4DDD-947A-B1E9B7AB861E @default.
- Q90596252 P304 Q90596252-E5F4A217-D6EA-406B-98B6-8DEDB5D54C61 @default.
- Q90596252 P31 Q90596252-231836A2-3E87-4635-9767-7F9F30DBAC7C @default.
- Q90596252 P356 Q90596252-04B7B4D4-B334-4E22-98C8-3A338ACCB4F0 @default.
- Q90596252 P478 Q90596252-D4A167AB-A608-453D-9B01-C2A1BD2EA579 @default.
- Q90596252 P50 Q90596252-340FA6E6-B8C8-414E-840B-909A82742AA0 @default.
- Q90596252 P50 Q90596252-6BCB1A46-ECBC-4B9D-9A7E-2AA3F1BD128C @default.
- Q90596252 P50 Q90596252-A16DE7B0-38AB-4FDA-BCF7-13AA7A9B6917 @default.
- Q90596252 P577 Q90596252-6D3F90CF-6EC7-4110-A095-142994159156 @default.
- Q90596252 P698 Q90596252-4664552D-E930-477E-80B5-7415AA43B6A6 @default.
- Q90596252 P356 J.AHJ.2018.05.015 @default.
- Q90596252 P698 30057012 @default.
- Q90596252 P1433 Q2227156 @default.
- Q90596252 P1476 "Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise" @default.
- Q90596252 P2093 "Emil Wolsk" @default.
- Q90596252 P2093 "Louise Balling" @default.
- Q90596252 P2093 "Steven R Goldsmith" @default.
- Q90596252 P2093 "Søren Boesgaard" @default.
- Q90596252 P304 "101-104" @default.
- Q90596252 P31 Q13442814 @default.
- Q90596252 P356 "10.1016/J.AHJ.2018.05.015" @default.
- Q90596252 P478 "203" @default.
- Q90596252 P50 Q41694276 @default.
- Q90596252 P50 Q44680687 @default.
- Q90596252 P50 Q44680701 @default.
- Q90596252 P577 "2018-06-14T00:00:00Z" @default.
- Q90596252 P698 "30057012" @default.